Herbalife Reports Third Quarter 2024 Results, Net Sales In Line with Expectations, Adjusted EBITDA¹ Exceeds Guidance; Raised Full-Year Adjusted EBITDA¹ Guidance
Go back to Herbalife Reports Third Quarter 2024 Results, Net Sales In Line with Expectations, Adjusted EBITDA¹ Exceeds Guidance; Raised Full-Year Adjusted EBITDA¹ Guidance| HERBALIFE LTD. (NYSE: HLF) | Delayed: 11.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.89 | 52 Week High | $72.22 | |||
| Open | $11.89 | 52 Week Low | $42.26 | |||
| Day High | $11.89 | P/E | 2.42 | |||
| Day Low | $11.89 | EPS | $4.91 | |||
| Volume | 45 | |||||
